1 June 2023 false No description of principal activity Taxfiler 2024.6 13408800business:PrivateLimitedCompanyLtd2023-06-012024-05-31 134088002023-05-31 134088002023-06-012024-05-31 13408800business:AuditExempt-NoAccountantsReport2023-06-012024-05-31 13408800business:FilletedAccounts2023-06-012024-05-31 134088002024-05-31 13408800business:Director12023-06-012024-05-31 13408800business:Director22023-06-012024-05-31 13408800business:RegisteredOffice2023-06-012024-05-31 134088002023-05-31 13408800core:AfterOneYear2024-05-31 13408800core:AfterOneYear2023-05-31 13408800core:ShareCapitalcore:PreviouslyStatedAmount2024-05-31 13408800core:ShareCapitalcore:PreviouslyStatedAmount2023-05-31 13408800core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-05-31 13408800core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-05-31 13408800core:PreviouslyStatedAmount2024-05-31 13408800core:PreviouslyStatedAmount2023-05-31 13408800business:SmallEntities2023-06-012024-05-31 13408800countries:EnglandWales2023-06-012024-05-31 13408800core:Goodwill2023-05-31 13408800core:Goodwill2024-05-31 13408800core:Goodwill2023-06-012024-05-31 134088002022-06-012023-05-31 iso4217:GBP xbrli:pure
Company Registration No. 13408800 (England and Wales)
KSG Pharma Ltd Unaudited accounts for the year ended 31 May 2024
KSG Pharma Ltd Unaudited accounts Contents
Page
- 2 -
KSG Pharma Ltd Company Information for the year ended 31 May 2024
Directors
Vamshi Krishna Gujjarlapoodi Bharathi Paladugu
Company Number
13408800 (England and Wales)
Registered Office
75 Maine Street Houlton Rugby Warwickshire CV23 1AS England
- 3 -
KSG Pharma Ltd Statement of financial position as at 31 May 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
8,400 
9,600 
Current assets
Cash at bank and in hand
5,177 
23,642 
Net current assets
5,177 
23,642 
Total assets less current liabilities
13,577 
33,242 
Creditors: amounts falling due after more than one year
(12,772)
(32,655)
Net assets
805 
587 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
705 
487 
Shareholders' funds
805 
587 
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 27 January 2025 and were signed on its behalf by
Vamshi Krishna Gujjarlapoodi Director Company Registration No. 13408800
- 4 -
KSG Pharma Ltd Notes to the Accounts for the year ended 31 May 2024
1
Statutory information
KSG Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 13408800. The registered office is 75 Maine Street, Houlton, Rugby, Warwickshire, CV23 1AS, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 June 2023
12,000 
At 31 May 2024
12,000 
Amortisation
At 1 June 2023
2,400 
Charge for the year
1,200 
At 31 May 2024
3,600 
Net book value
At 31 May 2024
8,400 
At 31 May 2023
9,600 
5
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Other creditors
6,000 
6,000 
Taxes and social security
6,431 
5,567 
Loans from directors
341 
21,088 
12,772 
32,655 
6
Average number of employees
During the year the average number of employees was 2 (2023: 2).
- 5 -